Concepedia

Mark Fulston

MF

Statistics

Publications

7

Citations

328

H-Index

7

Active since

1993

Affiliations

New Frontier(Current)

Mark Fulston is an author at New Frontier specializing in life sciences, biochemistry, and microbiology.

Publications per year

1993–2001

7

Publications

7

A Potent Seryl tRNA Synthetase Inhibitor SB-217452 Isolated from a Streptomyces species.

Anna L. Stefanska, Mark Fulston, C. S. V. HOUGE‐FRYDRYCH et al. · The Journal of Antibiotics · 2000 · 93 citations · Full text

, , +5

The identification of three new biosynthetic intermediates and one further biosynthetic enzyme in the clavulanic acid pathway

Stephen W. Elson, Keith H. Baggaley, Mark Davison et al. · Journal of the Chemical Society Chemical Communications · 1993 · 54 citations

, , +10

Isolation and Structure Determination of Two Novel Phenazines from a Streptomyces with Inhibitory Activity against Metallo-enzymes, Including Metallo-.BETA.-lactamase.

Martin L. Gilpin, Mark Fulston, David Payne et al. · The Journal of Antibiotics · 1995 · 54 citations · Full text

, , +7

SB-253514 and Analogues. Novel Inhibitors of Lipoprotein-Associated Phospholipase A2 Produced by Pseudomonas fluorescens DSM 11579. I. Fermentation of Producing Strain, Isolation and Biological Activity.

Jan E. Thirkettle, E. Alvarez, Helen Boyd et al. · The Journal of Antibiotics · 2000 · 51 citations · Full text

, , +11

Evidence that the immediate biosynthetic precursor of clavulanic acid is its N-aldehyde analogue

Neville Nicholson, Keith H. Baggaley, Robert Cassels et al. · Journal of the Chemical Society Chemical Communications · 1994 · 43 citations

, , +4

1–5 of 7